News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Quinn Anthony G.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 25,000 options to buy
@ $4.83, valued at
$120.8k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 80,079 shares
@ $2.344, valued at
$187.7k
|
|
| 03/15/2022 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 34,777 shares
@ $2.064, valued at
$71.8k
Bought 67,472 shares
@ $1.93, valued at
$130.2k
Bought 42,417 shares
@ $1.8611, valued at
$78.9k
|
|
| 02/22/2022 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $3.17, valued at
$1.1M
|
|
| 12/13/2021 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 43,108 shares
@ $3.7, valued at
$159.5k
Bought 10,526 shares
@ $3.75, valued at
$39.5k
|
|
| 10/29/2021 |
4
| Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Gifted 72,837 shares
@ $0
Gifted 72,837 shares
@ $0 |
|
| 07/01/2021 |
4
| Quinn Anthony G. (Director) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
| 06/11/2021 |
4
| Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 15,000 options to buy
@ $26.59, valued at
$398.9k
|
|
| 02/19/2021 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 330,000 options to buy
@ $7.35, valued at
$2.4M
|
|
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 52,000 options to buy
@ $19, valued at
$988k
|
|
| 06/11/2020 |
3
| Quinn Anthony G. (Director) has filed a Form 3 on Generation Bio Co. |
| 05/04/2020 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 165,000 shares
@ $4.75, valued at
$783.8k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Exercised 662 options to buy
@ $5.46, valued at
$3.6k
Exercised 17,603 options to buy
@ $6.31, valued at
$111.1k
|
|
| 06/14/2019 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 12,217 shares
@ $6.1148, valued at
$74.7k
Bought 14,406 shares
@ $6.1666, valued at
$88.8k
Bought 5,282 shares
@ $6.2311, valued at
$32.9k
|
|
| 05/22/2019 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 8,989 shares
@ $6.555, valued at
$58.9k
Bought 13,794 shares
@ $6.8857, valued at
$95k
Bought 3,809 shares
@ $6.8596, valued at
$26.1k
|
|
| 05/17/2019 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 719 shares
@ $7.098, valued at
$5.1k
Bought 6,256 shares
@ $6.7566, valued at
$42.3k
Bought 5,520 shares
@ $6.828, valued at
$37.7k
Bought 6,218 shares
@ $6.6477, valued at
$41.3k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/08/2019 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Exercised 1,323 options to buy
@ $5.46, valued at
$7.2k
Exercised 7,433 options to buy
@ $6.31, valued at
$46.9k
|
|
| 12/10/2018 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $6.02, valued at
$12k
Bought 994 shares
@ $9.13, valued at
$9.1k
Exercised 150,000 options to buy
@ $4.11, valued at
$616.5k
Exercised 3,306 options to buy
@ $5.46, valued at
$18.1k
Exercised 18,584 options to buy
@ $6.31, valued at
$117.3k
|
|
| 07/20/2018 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $9.36, valued at
$2.8M
Granted 75,000 options to buy
@ $9.36, valued at
$702k
Granted 50,000 options to buy
@ $9.36, valued at
$468k
|
|
| 07/16/2018 |
4
| Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Exercised 24,000 options to buy
@ $7.04, valued at
$169k
Exercised 14,866 options to buy
@ $6.31, valued at
$93.8k
|
|
| 07/13/2018 |
4
| Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Exercised 3,307 options to buy
@ $5.46, valued at
$18.1k
|
|
| 02/22/2018 |
4
| Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 178,400 options to buy
@ $6.31, valued at
$1.1M
|
|
| 02/20/2018 |
4
| Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Exercised 15,211 options to buy
@ $5.46, valued at
$83.1k
|
|
| 12/08/2017 |
4
| Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 4,888 shares
@ $4.9248, valued at
$24.1k
Bought 2,800 shares
@ $4.9882, valued at
$14k
Bought 600 shares
@ $5.065, valued at
$3k
|
|
| 12/05/2017 |
4
| Quinn Anthony G. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 4,100 shares
@ $4.5312, valued at
$18.6k
Bought 7,956 shares
@ $4.9804, valued at
$39.6k
Bought 5,065 shares
@ $4.931, valued at
$25k
|
|
| 09/01/2017 |
4
| Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $4.11, valued at
$616.5k
|
|
| 04/25/2017 |
4
| Quinn Anthony (interim Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc. |
|
|
|